Product Program year 2025 Source: CMS Open Payments

FINELINE II Sterox

Device Fineline_Crm

PDI 00802526060915

Open in the dashboard

General payments

$33,901

308 payments

Research payments

$0

0 payments

Through program year 2025, $33,901 in general payments and $0 in research payments were reported against FINELINE II Sterox (Fineline_Crm).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $854 48
2024 General $1,782 71
2023 General $29,870 110
2022 General $1,394 79

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $33,901 308 payments
Top recipients General payments · program year 2025
  1. Keith Kyker Clinical Cardiac Electrophysiology · Powell, TN $170 20% · 8 payments
  2. Cindy Namkung Nurse Practitioner, Family · New York, NY $50 6% · 4 payments
  3. Christopher Coughlin New York, NY $42 5% · 2 payments
  4. Shaina Emmanuel Physician Assistant · New York, NY $36 4% · 1 payment
  5. Allan Wicks Cardiovascular Disease · Casper, WY $35 4% · 1 payment

The top 5 of 32 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $352 43% · 12 practitioners
  2. Cardiovascular Disease Internal Medicine $134 16% · 8 practitioners
  3. Physician Assistant $87 11% · 3 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $79 10% · 2 practitioners
  5. Internal Medicine $59 7% · 3 practitioners

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $183 21% · 7 recipients
  2. Wyoming $176 21% · 5 recipients
  3. Tennessee $170 20% · 1 recipient
  4. California $104 12% · 4 recipients
  5. New Jersey $63 7% · 2 recipients

The top 5 of 14 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

308 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record